| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
CollPlant Biotechnologies (NASDAQ:CLGN) is set to give its latest quarterly earnings report on Wednesday, 2025-08-20. Here's what investors need to know before the announcement.
Analysts estimate that CollPlant Biotechnologies will report an earnings per share (EPS) of $0.06.
The market awaits CollPlant Biotechnologies's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
During the last quarter, the company reported an EPS missed by $0.10, leading to a 33.53% increase in the share price on the subsequent day.
Here's a look at CollPlant Biotechnologies's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | 0 | -0.13 | -0.37 | -0.35 |
| EPS Actual | -0.1 | -0.30 | -0.33 | -0.33 |
| Price Change % | 34.0% | -2.0% | -0.0% | 0.0% |
Shares of CollPlant Biotechnologies were trading at $2.66 as of August 18. Over the last 52-week period, shares are down 45.06%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CLGN
